The Patent Finder

Crossbeta Biosciences B.V.

Also on record
Records under this name other than patents Crossbeta Biosciences B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Crossbeta Biosciences B.V.

PatentTitleStatus Expires Confidence
US 11,104,725Amyloid beta oligomer specific binding molecule
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,498,147Diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases
Lapsed on the fee record
Ended Mar 3, 2021 · From the USPTO record
Lapsed on the fee recordEnded Mar 3, 2021From the USPTO record
US 8,158,585Cross-β structure comprising amyloid-binding proteins and methods for detection of the cross-β structure, for modulating cross-β structures fiber formation and modulating cross-β structure-mediated toxicity
Formerly held
Lapsed on the fee record
Ended Apr 17, 2020 · From the USPTO record
Lapsed on the fee recordEnded Apr 17, 2020From the USPTO record
US 8,114,832Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition
Lapsed on the fee record
Ended Feb 14, 2020 · From the USPTO record
Lapsed on the fee recordEnded Feb 14, 2020From the USPTO record
US 8,067,187Cross-β structure binding compounds
Lapsed on the fee record
Ended Nov 29, 2019 · From the USPTO record
Lapsed on the fee recordEnded Nov 29, 2019From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited